NeuroMetrix Inc
Change company Symbol lookup
Select an option...
NURO NeuroMetrix Inc
AIN Albany International Corp
BTVRF BlueRush Inc
GOLF Acushnet Holdings Corp
AA Alcoa Corp
CNCE Concert Pharmaceuticals Inc
BL Blackline Inc
DFEN Direxion Daily Aerospace & Defense Bull 3X Shares Direxion Daily Aerospace
NVRO Nevro Corp
DBI Designer Brands Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.

Closing Price
$4.54
Day's Change
-0.09 (-1.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.85
Day's Low
4.35
Volume
(Light)
Volume:
238,017

10-day average volume:
6,405,823
238,017

Shareholder Alert: Ademi LLP investigates whether CorePoint Lodging Inc. has obtained a Fair Price in its transaction with Highgate and Cerberus

10:32 am ET November 8, 2021 (PR Newswire) Print

Ademi LLP is investigating CorePoint (NYSE: CPLG), for possible breaches of fiduciary duty and other violations of law in its transaction with Highgate and Cerberus.

https://mma.prnewswire.com/media/1580107/Ademi_LLP_Logo.jpg

Click here to learn how to join the action: https://www.ademilaw.com/case/corepoint-lodging-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi LLP alleges CorePoint's financial outlook and prospects are excellent and yet CorePoint shareholders will receive only $15.65 per share in an all-cash transaction valued at approximately $1.5 billion. The merger agreement unreasonably limits competing bids for CorePoint by prohibiting solicitation of further bids, and imposing a significant penalty if CorePoint accepts a superior bid. CorePoint insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of CorePoint's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for CorePoint.

If you own CorePoint common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/corepoint-lodging-inc.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLPGuri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001

https://c212.net/c/img/favicon.png?sn=CG67422&sd=2021-11-08

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-corepoint-lodging-inc-has-obtained-a-fair-price-in-its-transaction-with-highgate-and-cerberus-301418473.html

SOURCE Ademi LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=CG67422&Transmission_Id=202111081032PR_NEWS_USPR_____CG67422&DateId=20211108

comtex tracking

COMTEX_396518320/1005/2021-11-08T10:32:08

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.